Endocannabinoid System & Athlete Mental Health Research Insights
Mental health outcomes retired athletes face are shaped by complex factors including brain trauma and identity loss. Research on the endocannabinoid system offers insights into these challenges. This article reviews key findings on mental health outcomes…
Cannabinoid Clinical Trials: CBD vs Placebo in Fibromyalgia Pain
This article reviews CBD for fibromyalgia clinical trial evidence, revealing no significant pain reduction compared to placebo. Despite widespread use, robust clinical support for CBD in fibromyalgia remains limited. These findings emphasize the need for…
Cannabinoid Clinical Trials: EEG Sleep Insomnia RCT
This pilot trial studied the acute effects oral cannabinoids sleep insomnia in 20 patients. The combination of THC and CBD reduced total sleep time and altered EEG sleep patterns. These findings highlight the complexity of cannabinoid effects on sleep in…
Endocannabinoid System Research: Trauma, Sleep & Substance Use
Insomnia symptoms trauma substance use risk is a key factor in developing problematic alcohol or cannabis use after trauma. This relationship is partly explained by posttraumatic stress symptoms. Clinicians should assess sleep disturbance as an early…
Cannabinoids for Autism: Clinical Evidence-Based Review
Cannabinoid clinical trials autism research shows promising signals for reducing irritability and hyperactivity in autism spectrum disorder. Evidence is limited by small sample sizes and trial variability. Larger, well-controlled studies are needed for…
Cannabinoid Clinical Trials for Anxiety and Tourette Syndrome
Effects of cannabinoid formulations on anxiety have been studied across multiple clinical trials, showing measurable symptom reductions. CBD and THC compounds demonstrate varying efficacy depending on formulation and condition. Evidence for Tourette…
Insights into Cannabis-Induced Psychosis and Schizophrenia Progression
Cannabis-induced psychosis schizophrenia progression insights reveal that a significant number of patients may develop schizophrenia spectrum disorders over time. Early identification of cannabis-induced psychosis is crucial for monitoring and…
Cannabinoid Clinical Trials: Cannabis in At-Risk Teens
Sequential messaging cannabis prevention offers a tailored approach for at-risk teens. This strategy challenges negative reactions before delivering targeted messages. Research shows it may improve prevention outcomes compared to standard campaigns.
Endocannabinoid System & CBD for Autism: RCT Evidence
This randomized controlled trial investigates the effects of cannabidiol on autism anxiety and social relating in children aged 5 to 12. The study shows potential benefits of CBD in reducing anxiety and parental stress. These findings provide important…
Endocannabinoid System & Autism: Maternal Cannabis Data
Maternal cannabis use peripregnancy child development risks include behavioral and developmental differences in early childhood. These risks vary depending on the presence of autism spectrum disorder symptoms. Understanding these associations is vital…